The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage.
about
Stromal Targets for Fluorescent-Guided Oncologic SurgeryCo-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor MicroenvironmentTranslating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer AssayPreoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times.The proportion of tumour cells is an independent predictor for survival in colorectal cancer patientsThe relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancerLINE-1 hypomethylation during primary colon cancer progressionPrognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer.Prognostic significance of tumour stroma ratio in inflammatory breast cancer.The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.The prognostic significance of tumour-stroma ratio in endometrial carcinomaSurveillance for early stages of colon cancer: potentials for optimizing follow-up protocols.Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.ASF-4-1 fibroblast-rich culture increases chemoresistance and mTOR expression of pancreatic cancer BxPC-3 cells at the invasive front in vitro, and promotes tumor growth and invasion in vivo.Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer.Liquid-based three-dimensional tumor models for cancer research and drug discovery.Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis: Correlations With Detailed Pathological FindingsClinical significance of stromal apoptosis in colorectal cancer.Lumican and versican are associated with good outcome in stage II and III colon cancer.The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trialProfiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer.The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progressionComment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'.[Tumor-stroma ratio is an independent prognostic factor of non-small cell lung cancer].QuPath: Open source software for digital pathology image analysis.Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study.Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.Prognostic markers for colorectal cancer; estimating ploidy and stroma.Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma.The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.
P2860
Q26774497-7F24EE77-009A-455F-8449-A47FBF8964A6Q28552528-E2DDB937-24DF-4EEB-A78F-0AFF82E5EEC3Q30497815-1E95B825-C5EA-45CC-9AD3-D4ECAE730DE1Q30587443-B882F65D-93AA-407F-9A44-9A3D5E52A111Q33847884-A50C2C25-BB45-4A83-8D45-332E57875B30Q33877484-D4D16109-E394-49BA-8699-93AC901398DCQ33886421-1AF72737-2F06-44E6-BA10-D6A9F7FC0FC2Q34658302-7B40D681-A370-45A9-BD1A-4DCFD7513164Q35103001-803B3438-BD02-4D80-8C08-062D52F7BA03Q35611945-62684EBC-AAF7-4D1A-8156-612760A94B88Q35870502-7D4C2E5B-63B6-4054-90BC-44030D7914AFQ36001990-0AA3E9AB-95A3-47B8-9E23-BE092F7AD6EDQ36662030-B7835CB2-F587-4CCA-A6F5-5399A3EB39B3Q36742326-B71F6F3C-267C-4AE1-B0D7-3C428DF893B6Q36810728-830C9490-946E-4A05-B18A-D1BB3292B11BQ36821123-044F6E32-27EF-4AA1-A405-5523C18766F1Q37107139-1F37DF70-5CD5-46A6-A370-453DD4FE1169Q37147318-CEBFC485-22E7-41A2-A38A-AFEFB4CA144FQ37204890-073145F5-673F-4A53-9979-D96F1A4A6D3BQ37330736-D4FBB574-35A9-4C51-94E3-7AF65FB2BA4CQ37379954-D95264E0-6A95-4A2A-8C24-5BFD774E0DAEQ37681755-04F5C645-B943-4923-92A0-229C2E5EC3FDQ37708880-C484C97A-3B9A-47D7-AF67-77BA4FEE92F4Q37718402-B05B76F5-70AD-43C7-A1FC-92BFF85B732AQ38987546-63CBF780-E82D-47B6-A6E1-DA79C9359757Q38998423-839271F0-909B-4C07-9556-97A93BFAD29BQ39133952-0EC55CED-D61D-4366-A711-88D59FDBF775Q39684656-C1E11650-1FF7-4395-AF9A-6D4F9DE6A09CQ39869474-1B0F5B6E-76D3-4F65-A372-4A2AA8D65050Q43171997-E5D36005-1CED-4EA2-AF1B-396803A370EEQ43172040-202A4230-3ACD-460B-A8FD-89D86375F8C9Q45190466-2B932B9C-FEF6-4196-81F7-28E8CDC7CC77Q47108040-8B8F1077-3EFE-478B-869E-C0BAD0FD2109Q47134831-7319AF60-D603-4C33-BB84-CAEF5A0E9DB9Q47147479-2B89F369-285E-44D2-8222-5F63D6F715AAQ47182054-F1E20907-1F27-415C-A137-6DE7799DE08DQ48353128-AA4DB484-A8D4-4EC0-8ACD-F564B1F0E3E5Q50026722-50B5DAF7-B2F7-4F1B-ADFF-DF953CAABCC3Q51045025-5028F835-3183-4F9B-8733-60B866870327Q52327733-25D7C96D-17C2-4F72-96D2-F9443776E470
P2860
The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The carcinoma-stromal ratio of ...... h node status and tumor stage.
@en
The carcinoma-stromal ratio of ...... h node status and tumor stage.
@nl
type
label
The carcinoma-stromal ratio of ...... h node status and tumor stage.
@en
The carcinoma-stromal ratio of ...... h node status and tumor stage.
@nl
prefLabel
The carcinoma-stromal ratio of ...... h node status and tumor stage.
@en
The carcinoma-stromal ratio of ...... h node status and tumor stage.
@nl
P2093
P1433
P1476
The carcinoma-stromal ratio of ...... h node status and tumor stage.
@en
P2093
Hans J Tanke
Hans Morreau
Jan M C Junggeburt
Karoly Szuhai
Pieter de Heer
Rob A E M Tollenaar
Wilma E Mesker
P304
P577
2007-01-01T00:00:00Z